Oss, Netherlands

Johannes Bernardus Maria Rewinkel


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Bram van de Bergstraat, NL (2002)
  • Oss, NL (2001 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Johannes Bernardus Maria Rewinkel

Introduction

Johannes Bernardus Maria Rewinkel is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of progesterone receptor modulators. With a total of 10 patents to his name, Rewinkel's work has had a considerable impact on medical science.

Latest Patents

Rewinkel's latest patents include innovative compounds that serve as progesterone receptor modulators. One of his inventions provides new modulators that are dibenzo[b,f]pyrido[1,2-d]oxazepine-2-amines or dibenzo[b,f]pyrido[1,2-d]thiazepine-2-amines, along with their various uses. Another significant patent features (cis)-8-fluorodibenzo[b,f]pyrido[1,2-d]oxazepine-1-amine compounds, which also have important applications in the medical field.

Career Highlights

Throughout his career, Rewinkel has worked with prominent companies such as Akzo Nobel N.V. and N.V. Organon. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.

Collaborations

Rewinkel has collaborated with esteemed colleagues, including Constant Adriaan Anton Van Boeckel and Philippus Johannes Marie Van Galen. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of his inventions.

Conclusion

Johannes Bernardus Maria Rewinkel's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…